BioCer Entwicklungs-GmbH is a young and innovative medical device company located in Bayreuth, Bavaria. We are specialized in research, development and production of innovative medical biomaterial products without animal or human components. Being a service provider, we offer innovative coating systems for existing implant systems and also develop new medical products for our customers.
BioCer Entwicklungs-GmbH commercializes innovative technologies developed in conjunction with leading national and international universities. BioCer’s primary scope is the development and production of plant based haemostatic materials, in order to assist medical professionals in the control of blood loss in a diverse range of complex surgical procedures. BioCer has also commercialized a unique advanced surface coating system made of titanium oxide, in order to improve the biocompatibility of surgical meshes for application in hernia repair and breast reconstruction.
HaemoCer™ PLUS Absorbable Polysaccharide Haemostat (APH) is a proprietary patent pending technology.
HaemoCer™ PLUS APH incorporates a sophisticated, plant-based polymer crosslinking that creates ultra-hydrophilic, biocompatible particles. Once in contact with blood, HaemoCer™ PLUS enhances the natural clotting cascade by rapidly dehydrating the blood and accelerating the concentration of platelets, red blood cells and coagulation proteins at the bleeding site.
TiO2Mesh™ is a surgical mesh implant specially indicated for repair of soft tissue defects of the abdominal wall, where a non-absorbable support material is required.
Relevant applications include the repair of inguinal and incisional hernias in all common surgical procedures and even IPOM. TiO2Mesh™ is made from a monofilament polypropylene thread and has a large-pored structure with blue orientation stripes. The single fibers of the mesh implants are completely covered by a high-purity and adherent titanium oxide surface coating to enhance the biocompatibility
HaemoCer™ PATCH is the latest development in the range of BioCer’s products. This patch is the perfect match to the HaemoCer™ Powder.
The plant-based patch is indicated for use in surgical procedures as an adjunct hemostat. The simple use guarantees an effective haemostasis by refining the natural blood clotting cascade. Latest studies demonstrate that plant based haemostatic materials (polysaccharides) like HaemoCer™ powder also reduce postoperative adhesions.
HaemoCer™Patch is CE registered since 01/2018 and already available in many countries.
Phone: +49 92178 7770-0
Fax: +49 92178 7770-79
Get in contact with German companies in 3 easy steps! With one single question you can reach all relevant German Pavilion exhibitors of your selected industrial branch.
Click here if you notice an image that violates copyright or privacy rights.